From: Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes
Drug type
Our approach
Hoehndorf’s approach
p-value
Non-targeted cancer therapies (chemotherapies)
9.5 %
25.8 %
p=0.023
Targeted cancer drugs
7.3 %
56.4 %
p=0.015
Non-cancer drugs
13.3 %
67.4 %
p=0.0006